Nitroimidazole Antimicrobial [EPC]

Nitroimidazole Antimicrobial [EPC] was reported 65942 times

Drugs of the Nitroimidazole Antimicrobial [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 VAGINAL FLATULENCE 251 0.8284
1 APPENDICOLITH 294 0.7597
2 SLEEP DISORDER THERAPY 137 0.6919
3 ANTACID THERAPY 87 0.6692
4 ANALGESIC THERAPY 133 0.4143
5 DRUG THERAPY 121 0.3569
6 ANTICOAGULANT THERAPY 85 0.2993
7 CONGENITAL HIATUS HERNIA 58 0.2544
8 BACTEROIDES INFECTION 53 0.2031
9 FEMALE GENITAL TRACT FISTULA 322 0.1884
10 TOXIC ENCEPHALOPATHY 678 0.1337
11 DYSMETRIA 72 0.1192
12 CEREBELLAR ATAXIA 109 0.1138
13 PSEUDOMEMBRANOUS COLITIS 254 0.1136
14 RADICULOPATHY 286 0.1084
15 PROCTITIS 300 0.1070
16 POUCHITIS 89 0.1034
17 CEREBELLAR SYNDROME 222 0.1012
18 BLOODY DISCHARGE 114 0.0997
19 FISTULA DISCHARGE 111 0.0879
20 HYPERPHOSPHATAEMIA 182 0.0846
21 CHRONIC SINUSITIS 314 0.0836
22 CLOSTRIDIUM DIFFICILE COLITIS 846 0.0797
23 INTERNATIONAL NORMALISED RATIO FLUCTUATION 163 0.0787
24 MEGACOLON 122 0.0776
25 ABORTION INCOMPLETE 140 0.0751
26 BLOOD PHOSPHORUS INCREASED 203 0.0743
27 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 68 0.0734
28 MACULAR DEGENERATION 862 0.0721
29 CLOSTRIDIUM COLITIS 87 0.0717
30 PELVIC ABSCESS 80 0.0696
31 ENTEROCUTANEOUS FISTULA 60 0.0680
32 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 70 0.0659
33 BACTERIAL VAGINOSIS 103 0.0658
34 DYSBIOSIS 54 0.0658
35 CLOSTRIDIUM TEST POSITIVE 141 0.0639
36 PERIRECTAL ABSCESS 69 0.0622
37 ANAL FISTULA 321 0.0601
38 RECTAL ABSCESS 100 0.0596
39 FIXED ERUPTION 98 0.0569
40 CLOSTRIDIAL INFECTION 187 0.0552
41 CLOSTRIDIUM DIFFICILE INFECTION 1198 0.0548
42 PATHOGEN RESISTANCE 493 0.0540
43 PELVIC INFLAMMATORY DISEASE 79 0.0529
44 LINEAR IGA DISEASE 88 0.0529
45 ACINETOBACTER INFECTION 57 0.0521
46 HYPERPARATHYROIDISM SECONDARY 129 0.0514
47 TOTAL LUNG CAPACITY DECREASED 82 0.0513
48 IRON DEFICIENCY 228 0.0506
49 NEPHROGENIC ANAEMIA 234 0.0505
50 VANISHING BILE DUCT SYNDROME 55 0.0493
51 ANAL ABSCESS 265 0.0491
52 LARGE INTESTINE INFECTION 60 0.0488
53 FISTULA 538 0.0478
54 ANAL FISSURE 252 0.0469
55 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 358 0.0460
56 ABSCESS INTESTINAL 99 0.0459
57 TONGUE COATED 77 0.0446
58 APPENDICITIS 409 0.0437
59 ENTEROCOLITIS HAEMORRHAGIC 64 0.0432
60 GASTROINTESTINAL WALL THICKENING 63 0.0421
61 NUCLEAR MAGNETIC RESONANCE IMAGING BRAIN ABNORMAL 61 0.0420
62 ABDOMINAL ABSCESS 174 0.0393
63 NEUROTOXICITY 648 0.0369
64 REBOUND ACID HYPERSECRETION 111 0.0367
65 VAGINAL DISCHARGE 368 0.0363
66 ORAL CANDIDIASIS 469 0.0356
67 LYME DISEASE 118 0.0354
68 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 176 0.0347
69 ENTEROCOCCAL INFECTION 164 0.0339
70 BILIARY DYSKINESIA 57 0.0336
71 BRAIN ABSCESS 85 0.0336
72 KOUNIS SYNDROME 76 0.0334
73 ANORECTAL DISORDER 66 0.0331
74 ATAXIA 392 0.0330
75 VENTRICULAR FIBRILLATION 356 0.0320
76 DIVERTICULAR PERFORATION 65 0.0316
77 BLOOD URIC ACID INCREASED 182 0.0315
78 CROHN'S DISEASE 216 0.0315
79 NEUTROPENIC COLITIS 65 0.0314
80 RASH MORBILLIFORM 87 0.0314
81 END STAGE RENAL DISEASE 567 0.0311
82 AORTIC STENOSIS 107 0.0307
83 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 790 0.0307
84 HYPOPHOSPHATAEMIA 226 0.0305
85 COLITIS 1144 0.0301
86 ROSACEA 140 0.0300
87 ABSCESS 457 0.0286
88 CHOLECYSTITIS CHRONIC 191 0.0285
89 FAECAL CALPROTECTIN INCREASED 89 0.0281
90 MULTIPLE ORGAN DYSFUNCTION SYNDROME 796 0.0281
91 LIVER ABSCESS 91 0.0280
92 DRUG LEVEL BELOW THERAPEUTIC 152 0.0275
93 LUNG OPACITY 72 0.0273
94 KLEBSIELLA INFECTION 137 0.0271
95 CHOLESTATIC LIVER INJURY 60 0.0269
96 TOXIC EPIDERMAL NECROLYSIS 407 0.0268
97 ILEOSTOMY 68 0.0266
98 CARDIOGENIC SHOCK 382 0.0266
99 PROCTALGIA 171 0.0266
100 MYASTHENIA GRAVIS 212 0.0262
101 SYSTEMIC CANDIDA 65 0.0259
102 PLEURITIC PAIN 71 0.0257
103 PARAESTHESIA ORAL 370 0.0256
104 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 57 0.0255
105 LONG QT SYNDROME 60 0.0250
106 ENCEPHALOPATHY 601 0.0244
107 DIVERTICULITIS 666 0.0240
108 TONGUE DISCOLOURATION 103 0.0235
109 NYSTAGMUS 125 0.0235
110 RETROPERITONEAL HAEMATOMA 52 0.0235
111 TYPE IV HYPERSENSITIVITY REACTION 64 0.0233
112 HAEMOLYTIC URAEMIC SYNDROME 52 0.0224
113 DIVERTICULUM INTESTINAL 98 0.0224
114 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 59 0.0222
115 CHOLESTASIS 426 0.0222
116 RASH MACULO-PAPULAR 473 0.0212
117 BACTERIAL INFECTION 395 0.0212
118 VAGINAL INFECTION 99 0.0210
119 CHOLECYSTITIS ACUTE 119 0.0210
120 LARGE INTESTINE PERFORATION 145 0.0209
121 HYPERLIPIDAEMIA 249 0.0208
122 MUCOUS STOOLS 103 0.0208
123 DERMATITIS EXFOLIATIVE 104 0.0208
124 COLITIS ISCHAEMIC 140 0.0207
125 BONE EROSION 72 0.0203
126 TENOSYNOVITIS 56 0.0203
127 DIVERTICULUM 144 0.0202
128 ABDOMINAL TENDERNESS 100 0.0201
129 SEPTIC SHOCK 875 0.0201
130 RENAL TUBULAR NECROSIS 196 0.0200
131 HAEMODYNAMIC INSTABILITY 152 0.0199
132 HEPATIC NECROSIS 75 0.0199
133 PYODERMA GANGRENOSUM 71 0.0197
134 HEPATIC CYST 67 0.0197
135 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 64 0.0197
136 PERIPHERAL SENSORY NEUROPATHY 115 0.0197
137 ASCITES 578 0.0196
138 INTESTINAL STENOSIS 82 0.0194
139 BENIGN PROSTATIC HYPERPLASIA 100 0.0193
140 CHROMATURIA 437 0.0193
141 FREQUENT BOWEL MOVEMENTS 521 0.0193
142 DIARRHOEA HAEMORRHAGIC 180 0.0192
143 DRUG LEVEL ABOVE THERAPEUTIC 88 0.0192
144 ERYTHEMA NODOSUM 67 0.0191
145 DERMATITIS EXFOLIATIVE GENERALISED 66 0.0190
146 ATELECTASIS 181 0.0187
147 AGRANULOCYTOSIS 348 0.0187
148 VENOOCCLUSIVE LIVER DISEASE 91 0.0184
149 EOSINOPHILIA 320 0.0182
150 ECONOMIC PROBLEM 276 0.0182
151 TROPONIN INCREASED 137 0.0180
152 RENAL CYST 143 0.0180
153 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 68 0.0178
154 TUBULOINTERSTITIAL NEPHRITIS 333 0.0177
155 CHRONIC KIDNEY DISEASE 1330 0.0175
156 BREATH SOUNDS ABNORMAL 86 0.0174
157 TOXIC SKIN ERUPTION 175 0.0174
158 DEAFNESS NEUROSENSORY 57 0.0173
159 ENTEROCOLITIS 100 0.0173
160 LEUKOCYTOSIS 311 0.0172
161 HEPATITIS CHOLESTATIC 103 0.0171
162 ENTERITIS 109 0.0170
163 CANDIDIASIS 68 0.0169
164 PSEUDOMONAS INFECTION 145 0.0169
165 SUBCUTANEOUS ABSCESS 81 0.0169
166 SMALL INTESTINAL OBSTRUCTION 205 0.0166
167 WOUND SECRETION 65 0.0166
168 BACTERAEMIA 196 0.0165
169 VASCULAR DEVICE INFECTION 74 0.0163
170 HAEMATOCHEZIA 896 0.0162
171 HEPATOCELLULAR INJURY 230 0.0162
172 TORSADE DE POINTES 127 0.0162
173 NECROTISING FASCIITIS 57 0.0162
174 RECTAL HAEMORRHAGE 692 0.0161
175 HELICOBACTER INFECTION 164 0.0159
176 LEUKOENCEPHALOPATHY 59 0.0158
177 SYNOVIAL CYST 73 0.0158
178 APHTHOUS ULCER 122 0.0157
179 ASPERGILLUS INFECTION 103 0.0157
180 PANCREATITIS ACUTE 352 0.0156
181 ACUTE HEPATIC FAILURE 214 0.0156
182 SWOLLEN TONGUE 484 0.0155
183 CANDIDA INFECTION 260 0.0154
184 HEPATITIS ACUTE 100 0.0154
185 MALNUTRITION 172 0.0154
186 GASTROINTESTINAL INFLAMMATION 120 0.0153
187 UTERINE PERFORATION 129 0.0152
188 ANHEDONIA 400 0.0152
189 HYPERREFLEXIA 53 0.0152
190 STAPHYLOCOCCAL SEPSIS 75 0.0152
191 ESCHERICHIA INFECTION 124 0.0151
192 THROMBOTIC THROMBOCYTOPENIC PURPURA 53 0.0150
193 ABSCESS LIMB 64 0.0150
194 BONE LESION 54 0.0150
195 HYPOVOLAEMIC SHOCK 71 0.0148
196 OLIGURIA 92 0.0148
197 JAUNDICE CHOLESTATIC 52 0.0147
198 HEPATITIS 376 0.0147
199 CHOLECYSTITIS 175 0.0147
200 HYPOALBUMINAEMIA 114 0.0146
201 DISSEMINATED INTRAVASCULAR COAGULATION 206 0.0146
202 COLITIS ULCERATIVE 653 0.0146
203 SPINAL OSTEOARTHRITIS 128 0.0146
204 CUTANEOUS VASCULITIS 53 0.0145
205 HALLUCINATIONS, MIXED 61 0.0145
206 LIPASE INCREASED 111 0.0145
207 GASTROENTERITIS 209 0.0143
208 BRONCHIECTASIS 96 0.0142
209 DYSARTHRIA 536 0.0142
210 LOW BIRTH WEIGHT BABY 113 0.0142
211 PROCEDURAL PAIN 393 0.0142
212 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 135 0.0141
213 INTERNATIONAL NORMALISED RATIO INCREASED 403 0.0141
214 GASTROINTESTINAL INFECTION 126 0.0140
215 HEPATIC CYTOLYSIS 179 0.0140
216 ULCER 223 0.0140
217 PROTHROMBIN TIME PROLONGED 83 0.0139
218 HYPERNATRAEMIA 69 0.0138
219 DERMATITIS BULLOUS 100 0.0138
220 SEPSIS 1537 0.0138
221 MULTI-ORGAN FAILURE 238 0.0138
222 RASH PUSTULAR 100 0.0137
223 HEPATOMEGALY 133 0.0135
224 BLOOD ALBUMIN DECREASED 107 0.0135
225 COAGULOPATHY 224 0.0134
226 RALES 78 0.0134
227 ABNORMAL FAECES 110 0.0134
228 ABDOMINAL PAIN 3120 0.0134
229 INTESTINAL PERFORATION 150 0.0133
230 PURULENT DISCHARGE 57 0.0133
231 METABOLIC ACIDOSIS 425 0.0133
232 LARGE INTESTINE POLYP 92 0.0133
233 HEPARIN-INDUCED THROMBOCYTOPENIA 65 0.0132
234 IMMUNE THROMBOCYTOPENIA 60 0.0131
235 NEURALGIA 316 0.0130
236 NEUROLOGICAL SYMPTOM 74 0.0129
237 NECROSIS 72 0.0129
238 INTESTINAL ISCHAEMIA 71 0.0129
239 TRICUSPID VALVE INCOMPETENCE 102 0.0128
240 PERIPHERAL VASCULAR DISORDER 66 0.0128
241 POLYNEUROPATHY 153 0.0128
242 HIATUS HERNIA 164 0.0127
243 BLOOD CALCIUM INCREASED 111 0.0126
244 APLASTIC ANAEMIA 66 0.0126
245 SPRUE-LIKE ENTEROPATHY 62 0.0126
246 ILEUS PARALYTIC 56 0.0125
247 GASTROINTESTINAL SOUNDS ABNORMAL 62 0.0125
248 STAPHYLOCOCCAL INFECTION 412 0.0125
249 HYPOVOLAEMIA 73 0.0125
250 HYPERCHOLESTEROLAEMIA 120 0.0124
251 ACUTE KIDNEY INJURY 1893 0.0124
252 HAEMORRHOIDS 238 0.0122
253 ABDOMINAL PAIN LOWER 308 0.0122
254 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 208 0.0121
255 DRUG LEVEL DECREASED 123 0.0121
256 NEUTROPENIC SEPSIS 86 0.0120
257 GINGIVAL SWELLING 53 0.0120
258 ANGIOEDEMA 527 0.0119
259 TENDONITIS 183 0.0118
260 COMPRESSION FRACTURE 63 0.0117
261 HYPONATRAEMIA 660 0.0117
262 RENAL FAILURE 1552 0.0117
263 GRAFT VERSUS HOST DISEASE 84 0.0117
264 HYPERBILIRUBINAEMIA 121 0.0117
265 TENDON DISORDER 76 0.0116
266 ABORTION SPONTANEOUS 465 0.0116
267 RHEUMATOID FACTOR POSITIVE 67 0.0116
268 OSTEOPENIA 176 0.0116
269 ANAPHYLACTIC REACTION 640 0.0116
270 RENAL FAILURE CHRONIC 89 0.0116
271 RED BLOOD CELL SEDIMENTATION RATE INCREASED 128 0.0116
272 FAILURE TO THRIVE 60 0.0115
273 MITRAL VALVE INCOMPETENCE 130 0.0115
274 ELECTROLYTE IMBALANCE 133 0.0114
275 FAECES DISCOLOURED 248 0.0114
276 POOR VENOUS ACCESS 118 0.0114
277 ILEUS 141 0.0113
278 STEVENS-JOHNSON SYNDROME 251 0.0113
279 CHOLELITHIASIS 370 0.0113
280 JAUNDICE 302 0.0112
281 SKIN NECROSIS 58 0.0112
282 INTESTINAL RESECTION 60 0.0111
283 TENDON PAIN 84 0.0111
284 HEPATIC FAILURE 334 0.0111
285 DRUG SPECIFIC ANTIBODY PRESENT 72 0.0111
286 TENDERNESS 115 0.0110
287 MENTAL STATUS CHANGES 306 0.0110
288 GOUT 197 0.0110
289 BLOOD ALKALINE PHOSPHATASE INCREASED 270 0.0109
290 C-REACTIVE PROTEIN INCREASED 395 0.0108
291 INTERVERTEBRAL DISC DEGENERATION 100 0.0108
292 VULVOVAGINAL PAIN 52 0.0108
293 PREMATURE LABOUR 61 0.0108
294 LUNG INFILTRATION 95 0.0107
295 HYPERTHERMIA 82 0.0107
296 HYPOKALAEMIA 494 0.0107
297 ABDOMINAL DISTENSION 1113 0.0107
298 VULVOVAGINAL PRURITUS 54 0.0107
299 PLATELET COUNT INCREASED 139 0.0107
300 OSTEOMYELITIS 193 0.0106
301 ANURIA 91 0.0106
302 HAEMOLYTIC ANAEMIA 94 0.0105
303 ACIDOSIS 80 0.0105
304 TACHYPNOEA 142 0.0104
305 MOUTH ULCERATION 220 0.0104
306 DYSLIPIDAEMIA 53 0.0104
307 ASPIRATION 114 0.0104
308 PELVIC PAIN 188 0.0103
309 BLOOD BILIRUBIN INCREASED 279 0.0103
310 RENAL FAILURE ACUTE 438 0.0103
311 SWELLING FACE 671 0.0103
312 DRUG-INDUCED LIVER INJURY 323 0.0103
313 PANCYTOPENIA 575 0.0103
314 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 77 0.0103
315 TOOTH ABSCESS 104 0.0102
316 MUCOSAL INFLAMMATION 267 0.0102
317 IRON DEFICIENCY ANAEMIA 94 0.0102
318 NEPHROPATHY TOXIC 114 0.0101
319 CARDIOMEGALY 124 0.0101
320 LIVER FUNCTION TEST ABNORMAL 292 0.0100
321 SINUS TACHYCARDIA 142 0.0100
322 INJURY 702 0.0100
323 ENCEPHALITIS 69 0.0100
324 SKIN WARM 58 0.0100
325 PETECHIAE 104 0.0100
326 PLEURAL EFFUSION 606 0.0099
327 DRUG RESISTANCE 255 0.0099
328 STREPTOCOCCAL INFECTION 55 0.0099
329 NEUROPATHY PERIPHERAL 936 0.0098
330 GAMMA-GLUTAMYLTRANSFERASE INCREASED 218 0.0098
331 PURPURA 87 0.0098
332 HYPOXIA 346 0.0098
333 APPETITE DISORDER 65 0.0098
334 PREMATURE DELIVERY 156 0.0098
335 DRUG INTOLERANCE 944 0.0098
336 GALLBLADDER DISORDER 174 0.0097
337 OVARIAN CYST 97 0.0097
338 PYREXIA 3357 0.0097
339 TOOTH INFECTION 127 0.0096
340 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 526 0.0096
341 SENSORY LOSS 77 0.0096
342 DEFAECATION URGENCY 67 0.0096
343 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 678 0.0095
344 ERYTHEMA MULTIFORME 88 0.0094
345 MYOCLONUS 112 0.0094
346 CYTOMEGALOVIRUS INFECTION 156 0.0094
347 FULL BLOOD COUNT ABNORMAL 99 0.0094
348 RENAL INJURY 278 0.0093
349 ACUTE RESPIRATORY DISTRESS SYNDROME 165 0.0093
350 POSTOPERATIVE WOUND INFECTION 63 0.0093
351 EAR PAIN 181 0.0093
352 GENERALISED OEDEMA 115 0.0093
353 BRONCHOPULMONARY ASPERGILLOSIS 72 0.0093
354 PREMATURE BABY 277 0.0092
355 C-REACTIVE PROTEIN ABNORMAL 59 0.0092
356 MICTURITION URGENCY 105 0.0092
357 VASCULITIS 107 0.0092
358 MELAENA 202 0.0092
359 FLANK PAIN 86 0.0092
360 RESPIRATORY FAILURE 669 0.0092
361 POLYP 60 0.0092
362 ANAEMIA 1746 0.0091
363 ORAL DISORDER 67 0.0091
364 NIGHT SWEATS 293 0.0091
365 FAECES SOFT 66 0.0091
366 ASPARTATE AMINOTRANSFERASE INCREASED 482 0.0091
367 DEVICE RELATED INFECTION 139 0.0090
368 UTERINE LEIOMYOMA 66 0.0090
369 SKIN ULCER 233 0.0090
370 BLOOD PRESSURE FLUCTUATION 216 0.0090
371 RESPIRATORY DISTRESS 248 0.0090
372 DERMATITIS ALLERGIC 113 0.0090
373 POST PROCEDURAL INFECTION 73 0.0090
374 ANAL INCONTINENCE 80 0.0089
375 INFLAMMATORY BOWEL DISEASE 87 0.0089
376 COORDINATION ABNORMAL 124 0.0089
377 INTESTINAL OBSTRUCTION 335 0.0089
378 DEFORMITY 83 0.0089
379 SECRETION DISCHARGE 111 0.0089
380 DECUBITUS ULCER 72 0.0088
381 CARDIAC FLUTTER 57 0.0088
382 LEUKOPENIA 440 0.0088
383 OESOPHAGITIS 96 0.0088
384 ACUTE RESPIRATORY FAILURE 169 0.0088
385 FACE OEDEMA 148 0.0088
386 HIDRADENITIS 80 0.0088
387 FUNGAL INFECTION 292 0.0088
388 PAROSMIA 66 0.0087
389 CARDIAC MURMUR 75 0.0087
390 PYELONEPHRITIS 75 0.0086
391 PERITONITIS 179 0.0086
392 BLOOD TEST ABNORMAL 121 0.0086
393 ECCHYMOSIS 59 0.0086
394 THROMBOCYTOPENIA 961 0.0086
395 DYSGEUSIA 638 0.0086
396 GENERAL PHYSICAL HEALTH DETERIORATION 993 0.0086
397 UROSEPSIS 79 0.0086
398 FEBRILE NEUTROPENIA 568 0.0086
399 BLOOD PRESSURE DIASTOLIC DECREASED 63 0.0085
400 SHOCK 196 0.0085
401 DRUG ERUPTION 151 0.0085
402 ARTERIOSCLEROSIS 80 0.0085
403 HYPOPHAGIA 217 0.0085
404 PULMONARY MASS 126 0.0085
405 BLEPHAROSPASM 53 0.0084
406 WHITE BLOOD CELL COUNT INCREASED 322 0.0084
407 VENTRICULAR TACHYCARDIA 138 0.0083
408 SUPRAVENTRICULAR TACHYCARDIA 80 0.0083
409 ANAPHYLACTIC SHOCK 214 0.0083
410 SCAR 142 0.0083
411 DRUG INTERACTION 1314 0.0083
412 TACHYCARDIA 735 0.0083
413 MULTIPLE INJURIES 52 0.0083
414 NERVOUS SYSTEM DISORDER 257 0.0082
415 CHOLECYSTECTOMY 94 0.0082
416 IRRITABLE BOWEL SYNDROME 175 0.0082
417 PULMONARY EMBOLISM 775 0.0081
418 TRANSAMINASES INCREASED 181 0.0081
419 DENTAL CARIES 90 0.0081
420 ORAL PAIN 182 0.0081
421 ELECTROCARDIOGRAM QT PROLONGED 291 0.0081
422 MANIA 133 0.0081
423 OSTEONECROSIS OF JAW 200 0.0081
424 DUODENAL ULCER 57 0.0081
425 GASTRITIS 212 0.0080
426 HEPATIC ENCEPHALOPATHY 75 0.0080
427 GENERALISED TONIC-CLONIC SEIZURE 133 0.0080
428 SHOCK HAEMORRHAGIC 65 0.0080
429 PHARYNGITIS 99 0.0080
430 VITAMIN D DECREASED 68 0.0079
431 MENINGITIS 53 0.0079
432 PHARYNGEAL OEDEMA 122 0.0079
433 SKIN LESION 217 0.0079
434 OEDEMA 429 0.0079
435 BONE DISORDER 144 0.0079
436 ALANINE AMINOTRANSFERASE INCREASED 483 0.0079
437 INFUSION RELATED REACTION 521 0.0079
438 FACIAL PAIN 70 0.0078
439 DYSPEPSIA 770 0.0078
440 VITAMIN D DEFICIENCY 76 0.0078
441 LEFT VENTRICULAR DYSFUNCTION 52 0.0078
442 PARAESTHESIA 1216 0.0077
443 BOWEL MOVEMENT IRREGULARITY 59 0.0077
444 PHARYNGEAL SWELLING 75 0.0077
445 CELLULITIS 385 0.0076
446 INTENTIONAL PRODUCT USE ISSUE 669 0.0076
447 DEEP VEIN THROMBOSIS 496 0.0076
448 PHOTOPHOBIA 143 0.0076
449 SPUTUM DISCOLOURED 72 0.0076
450 BLOOD MAGNESIUM DECREASED 65 0.0075
451 VOMITING 3535 0.0075
452 SWELLING 703 0.0075
453 BURSITIS 91 0.0075
454 OSTEOARTHRITIS 317 0.0075
455 EXPOSURE DURING PREGNANCY 464 0.0075
456 OSTEOPOROSIS 307 0.0075
457 WEIGHT FLUCTUATION 78 0.0074
458 PRODUCT ADMINISTRATION INTERRUPTED 58 0.0074
459 HAEMODIALYSIS 62 0.0074
460 HYDRONEPHROSIS 55 0.0073
461 SINUS BRADYCARDIA 71 0.0073
462 CONFUSIONAL STATE 1186 0.0073
463 URINE OUTPUT DECREASED 64 0.0073
464 DYSPHONIA 428 0.0073
465 TINNITUS 336 0.0073
466 BODY TEMPERATURE INCREASED 149 0.0073
467 GASTROOESOPHAGEAL REFLUX DISEASE 585 0.0073
468 HAEMATOTOXICITY 69 0.0073
469 CONDITION AGGRAVATED 2206 0.0072
470 HEART RATE IRREGULAR 163 0.0072
471 BODY TEMPERATURE DECREASED 71 0.0072
472 DRUG LEVEL INCREASED 119 0.0072
473 LIGAMENT SPRAIN 71 0.0072
474 DELIRIUM 249 0.0072
475 SPLENOMEGALY 84 0.0072
476 HAEMATEMESIS 181 0.0071
477 INTERVERTEBRAL DISC PROTRUSION 156 0.0071
478 PNEUMOTHORAX 113 0.0071
479 LIP SWELLING 237 0.0071
480 ALTERED STATE OF CONSCIOUSNESS 154 0.0071
481 RESPIRATORY RATE INCREASED 63 0.0071
482 POLYURIA 58 0.0071
483 GRAND MAL CONVULSION 65 0.0070
484 DYSURIA 259 0.0070
485 LOWER GASTROINTESTINAL HAEMORRHAGE 52 0.0070
486 BLOOD CREATININE INCREASED 458 0.0070
487 LYMPHADENOPATHY 248 0.0070
488 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 365 0.0070
489 CIRCULATORY COLLAPSE 119 0.0070
490 INFLAMMATION 358 0.0069
491 CYANOSIS 109 0.0069
492 LIVER INJURY 169 0.0069
493 THROMBOTIC MICROANGIOPATHY 67 0.0069
494 DEHYDRATION 917 0.0069
495 PANCREATITIS 363 0.0069
496 HYPERKALAEMIA 240 0.0068
497 DISORIENTATION 271 0.0068
498 CONSTIPATION 1491 0.0068
499 CORONARY ARTERY DISEASE 206 0.0068
500 GINGIVAL PAIN 54 0.0068
501 FEAR 182 0.0068
502 HAEMATOCRIT DECREASED 134 0.0068
503 HYPOMAGNESAEMIA 94 0.0067
504 NEPHROPATHY 63 0.0067
505 RASH ERYTHEMATOUS 322 0.0067
506 EYE INFECTION 76 0.0067
507 INFECTION 972 0.0067
508 TREATMENT FAILURE 556 0.0067
509 NEUTROPENIA 911 0.0067
510 ROTATOR CUFF SYNDROME 86 0.0067
511 HEPATIC STEATOSIS 124 0.0067
512 SPINAL COMPRESSION FRACTURE 55 0.0066
513 DIARRHOEA 4291 0.0066
514 HEPATOTOXICITY 148 0.0066
515 PNEUMONIA ASPIRATION 166 0.0066
516 DYSPHAGIA 630 0.0066
517 WEIGHT DECREASED 1847 0.0066
518 BLOOD CHOLESTEROL INCREASED 308 0.0066
519 IMPAIRED GASTRIC EMPTYING 90 0.0066
520 SKIN LACERATION 71 0.0065
521 BRONCHOSPASM 93 0.0065
522 HYPOAESTHESIA 975 0.0065
523 HYPOTONIA 65 0.0065
524 PARANOIA 112 0.0065
525 LIVER DISORDER 288 0.0065
526 LOWER RESPIRATORY TRACT INFECTION 295 0.0065
527 PHOTOSENSITIVITY REACTION 107 0.0065
528 ANXIETY 1833 0.0064
529 MUSCULOSKELETAL STIFFNESS 564 0.0064
530 UNRESPONSIVE TO STIMULI 166 0.0064
531 BLOOD POTASSIUM DECREASED 193 0.0064
532 RASH GENERALISED 166 0.0064
533 ORAL HERPES 125 0.0064
534 WOUND INFECTION 70 0.0064
535 CHILLS 749 0.0064
536 PSYCHOLOGICAL TRAUMA 55 0.0064
537 GASTROINTESTINAL PAIN 70 0.0064
538 PAIN IN JAW 180 0.0063
539 HEART RATE DECREASED 223 0.0063
540 OBESITY 101 0.0063
541 LACTIC ACIDOSIS 204 0.0063
542 APHASIA 190 0.0063
543 RASH PAPULAR 141 0.0063
544 MYOCARDITIS 72 0.0063
545 HEAD DISCOMFORT 111 0.0063
546 HYPOTENSION 1256 0.0063
547 SEROTONIN SYNDROME 120 0.0062
548 NAUSEA 4939 0.0062
549 HALLUCINATION, AUDITORY 99 0.0062
550 BLOOD CALCIUM DECREASED 70 0.0062
551 DECREASED ACTIVITY 67 0.0062
552 NERVE INJURY 69 0.0062
553 PRODUCT TASTE ABNORMAL 84 0.0062
554 TOOTHACHE 112 0.0062
555 HALLUCINATION 465 0.0062
556 TOOTH FRACTURE 68 0.0062
557 HALLUCINATION, VISUAL 130 0.0062
558 VERTIGO 375 0.0061
559 BONE MARROW FAILURE 125 0.0061
560 SKIN INFECTION 69 0.0061
561 MATERNAL EXPOSURE DURING PREGNANCY 547 0.0061
562 ABDOMINAL PAIN UPPER 1260 0.0061
563 FLATULENCE 347 0.0061
564 FLUID OVERLOAD 89 0.0061
565 DRY MOUTH 496 0.0061
566 OBSTRUCTIVE AIRWAYS DISORDER 68 0.0061
567 LIVER FUNCTION TEST INCREASED 131 0.0061
568 GASTROINTESTINAL DISORDER 546 0.0061
569 ATRIAL SEPTAL DEFECT 51 0.0061
570 SLEEP APNOEA SYNDROME 116 0.0061
571 NECK PAIN 339 0.0061
572 NEUTROPHIL COUNT INCREASED 62 0.0060
573 IMMUNOSUPPRESSION 53 0.0060
574 OEDEMA PERIPHERAL 732 0.0060
575 EMOTIONAL DISTRESS 724 0.0060
576 RASH MACULAR 209 0.0060
577 ERYTHEMA 1225 0.0060
578 PARKINSONISM 58 0.0059
579 STATUS EPILEPTICUS 67 0.0059
580 BLOOD LACTATE DEHYDROGENASE INCREASED 94 0.0059
581 BLISTER 333 0.0059
582 DEAFNESS 155 0.0059
583 HYPERCALCAEMIA 73 0.0059
584 BLOOD UREA INCREASED 98 0.0058
585 ADRENAL INSUFFICIENCY 71 0.0058
586 BLOOD PRESSURE SYSTOLIC INCREASED 114 0.0058
587 UPPER RESPIRATORY TRACT INFECTION 270 0.0058
588 CYSTITIS 186 0.0058
589 DERMATITIS 122 0.0058
590 ANOREXIA 75 0.0058
591 BLOOD IRON DECREASED 69 0.0058
592 CARDIO-RESPIRATORY ARREST 243 0.0058
593 PALLOR 158 0.0058
594 EXOSTOSIS 53 0.0058
595 EJECTION FRACTION DECREASED 90 0.0058
596 RIB FRACTURE 119 0.0058
597 BLOOD SODIUM DECREASED 109 0.0058
598 POST PROCEDURAL COMPLICATION 111 0.0058
599 BURNING SENSATION 405 0.0058
600 THROMBOSIS 463 0.0057
601 CENTRAL NERVOUS SYSTEM LESION 79 0.0057
602 HAEMOPTYSIS 160 0.0057
603 HAEMOGLOBIN DECREASED 588 0.0057
604 RASH PRURITIC 309 0.0057
605 PERIPHERAL COLDNESS 78 0.0057
606 IMPAIRED HEALING 186 0.0057
607 HYPERSENSITIVITY 1051 0.0057
608 MUSCLE TWITCHING 130 0.0056
609 HAEMATOMA 146 0.0056
610 IMPAIRED QUALITY OF LIFE 81 0.0056
611 PANIC ATTACK 205 0.0056
612 FEEDING DISORDER 114 0.0056
613 VENTRICULAR EXTRASYSTOLES 58 0.0056
614 HYPOKINESIA 81 0.0056
615 CARDIAC ARREST 460 0.0056
616 URTICARIA 932 0.0056
617 CYST 69 0.0056
618 EMPHYSEMA 56 0.0055
619 HEMIPARESIS 94 0.0055
620 FOETAL EXPOSURE DURING PREGNANCY 451 0.0055
621 PULMONARY FIBROSIS 106 0.0055
622 JOINT INJURY 118 0.0055
623 HAEMATURIA 189 0.0055
624 QUALITY OF LIFE DECREASED 74 0.0055
625 CARPAL TUNNEL SYNDROME 77 0.0055
626 DIPLOPIA 142 0.0055
627 URINARY TRACT INFECTION 929 0.0054
628 JOINT RANGE OF MOTION DECREASED 73 0.0054
629 ATRIAL FIBRILLATION 529 0.0054
630 THINKING ABNORMAL 101 0.0054
631 CARDIOMYOPATHY 80 0.0054
632 EATING DISORDER 115 0.0054
633 PULMONARY CONGESTION 71 0.0054
634 GASTROINTESTINAL HAEMORRHAGE 450 0.0054
635 THERAPY NON-RESPONDER 242 0.0054
636 EAR DISCOMFORT 55 0.0054
637 SLEEP DISORDER 378 0.0054
638 WOUND 149 0.0053
639 MUSCULOSKELETAL CHEST PAIN 82 0.0053
640 MASS 74 0.0053
641 ACUTE MYOCARDIAL INFARCTION 156 0.0053
642 DECREASED APPETITE 1228 0.0053
643 HYPOCALCAEMIA 100 0.0053
644 LUNG INFECTION 82 0.0053
645 SKIN DISORDER 176 0.0053
646 PHARYNGITIS STREPTOCOCCAL 57 0.0053
647 DRUG EXPOSURE DURING PREGNANCY 179 0.0053
648 EMBEDDED DEVICE 52 0.0052
649 PSYCHOTIC DISORDER 155 0.0052
650 PARALYSIS 75 0.0052
651 DIABETES MELLITUS 399 0.0052
652 HEPATIC CIRRHOSIS 98 0.0052
653 FEELING COLD 145 0.0052
654 INCONTINENCE 55 0.0052
655 ACUTE MYELOID LEUKAEMIA 81 0.0052
656 RENAL IMPAIRMENT 436 0.0052
657 PULMONARY HYPERTENSION 108 0.0052
658 TENDON RUPTURE 64 0.0052
659 EYELID OEDEMA 60 0.0052
660 RHABDOMYOLYSIS 215 0.0052
661 MUSCULAR WEAKNESS 584 0.0051
662 METASTASES TO BONE 84 0.0051
663 HYPOAESTHESIA ORAL 77 0.0051
664 DYSTONIA 99 0.0051
665 PAIN 3130 0.0051
666 SPEECH DISORDER 266 0.0051
667 FOOT FRACTURE 96 0.0051
668 LOCALISED INFECTION 122 0.0050
669 COMA 240 0.0050
670 NOCTURIA 61 0.0050
671 LETHARGY 289 0.0050
672 LYMPHOPENIA 71 0.0050
673 PRESYNCOPE 122 0.0050
674 UVEITIS 68 0.0050
675 HAEMORRHAGE 524 0.0050
676 ASTHENIA 1881 0.0050
677 DRUG TOXICITY 68 0.0050
678 BIPOLAR DISORDER 54 0.0050
679 FOOT DEFORMITY 55 0.0050
680 DEPRESSED LEVEL OF CONSCIOUSNESS 196 0.0049
681 OFF LABEL USE 4324 0.0049
682 CONVULSION 282 0.0049
683 DEPRESSION 1121 0.0049
684 WRIST FRACTURE 59 0.0049
685 HEADACHE 3084 0.0049
686 GENITAL HAEMORRHAGE 63 0.0049
687 CRYING 178 0.0049
688 BRAIN OEDEMA 61 0.0048
689 INFUSION SITE PAIN 62 0.0048
690 SINUS CONGESTION 65 0.0048
691 CAESAREAN SECTION 56 0.0048
692 GLOMERULAR FILTRATION RATE DECREASED 59 0.0048
693 CONJUNCTIVITIS 89 0.0048
694 NEPHROLITHIASIS 220 0.0048
695 PULMONARY OEDEMA 214 0.0048
696 MUSCLE RIGIDITY 57 0.0048
697 LOCAL SWELLING 83 0.0048
698 MALAISE 2085 0.0047
699 CHEST DISCOMFORT 486 0.0047
700 MYOCARDIAL ISCHAEMIA 54 0.0047
701 MENTAL IMPAIRMENT 115 0.0047
702 OROPHARYNGEAL PAIN 439 0.0047
703 PRODUCTIVE COUGH 226 0.0047
704 RESPIRATORY DEPRESSION 58 0.0047
705 CARDIOVASCULAR DISORDER 120 0.0047
706 URINARY INCONTINENCE 140 0.0047
707 TREMOR 782 0.0047
708 PRODUCT USE IN UNAPPROVED INDICATION 1167 0.0047
709 WHEEZING 279 0.0047
710 CHEST PAIN 871 0.0047
711 DYSPNOEA EXERTIONAL 177 0.0047
712 THROAT TIGHTNESS 127 0.0047
713 SOMNOLENCE 944 0.0047
714 SKIN REACTION 66 0.0047
715 RESPIRATORY TRACT INFECTION 122 0.0047
716 PALPITATIONS 548 0.0047
717 SEASONAL ALLERGY 66 0.0047
718 HEART RATE INCREASED 461 0.0046
719 ORTHOSTATIC HYPOTENSION 81 0.0046
720 GAIT INABILITY 155 0.0046
721 HYPERGLYCAEMIA 169 0.0046
722 SYNCOPE 463 0.0046
723 RASH 2017 0.0046
724 GAIT DISTURBANCE 885 0.0046
725 DIZZINESS 2304 0.0046
726 ORAL DISCOMFORT 64 0.0046
727 GASTROENTERITIS VIRAL 83 0.0046
728 PREGNANCY 92 0.0046
729 TOOTH DISORDER 102 0.0046
730 IMPAIRED WORK ABILITY 98 0.0046
731 RED BLOOD CELL COUNT DECREASED 131 0.0046
732 MYALGIA 778 0.0046
733 BRONCHITIS 338 0.0046
734 SENSORY DISTURBANCE 73 0.0045
735 LIMB DISCOMFORT 140 0.0045
736 MUSCULOSKELETAL PAIN 237 0.0045
737 PROTEINURIA 86 0.0045
738 HYPERTENSION 958 0.0045
739 NO THERAPEUTIC RESPONSE 55 0.0045
740 RETCHING 96 0.0045
741 MUSCLE ATROPHY 57 0.0045
742 HYPOGLYCAEMIA 218 0.0045
743 MENTAL DISORDER 195 0.0045
744 BACK PAIN 1040 0.0045
745 ANGINA PECTORIS 128 0.0045
746 BRAIN FOG 70 0.0045
747 UPPER GASTROINTESTINAL HAEMORRHAGE 75 0.0045
748 FEELING HOT 273 0.0044
749 SINUSITIS 456 0.0044
750 LUNG DISORDER 218 0.0044
751 METASTASES TO LIVER 78 0.0044
752 PERICARDIAL EFFUSION 102 0.0044
753 DYSKINESIA 179 0.0044
754 SCIATICA 70 0.0044
755 STOMATITIS 266 0.0044
756 LYMPHOCYTE COUNT DECREASED 77 0.0044
757 PRURITUS 1674 0.0044
758 TOXICITY TO VARIOUS AGENTS 733 0.0043
759 HEPATIC ENZYME INCREASED 296 0.0043
760 ERUCTATION 84 0.0043
761 PNEUMONIA 1400 0.0043
762 RESTLESSNESS 158 0.0043
763 THERAPEUTIC RESPONSE SHORTENED 143 0.0043
764 DRUG INEFFECTIVE 5662 0.0043
765 BLOOD PRESSURE DECREASED 285 0.0043
766 GLOSSODYNIA 96 0.0043
767 RESPIRATORY TRACT CONGESTION 68 0.0043
768 BONE DENSITY DECREASED 134 0.0043
769 ARTHRALGIA 1773 0.0043
770 CONTUSION 410 0.0043
771 EPILEPSY 130 0.0042
772 AGITATION 312 0.0042
773 GINGIVAL BLEEDING 58 0.0042
774 VIRAL INFECTION 141 0.0042
775 DISEASE RECURRENCE 201 0.0042
776 EYE SWELLING 156 0.0042
777 ABDOMINAL DISCOMFORT 703 0.0042
778 TASTE DISORDER 85 0.0042
779 DEPRESSED MOOD 221 0.0042
780 BLOOD PRESSURE INCREASED 638 0.0042
781 BLOOD URINE PRESENT 79 0.0042
782 PAIN IN EXTREMITY 1226 0.0042
783 SYNOVITIS 75 0.0042
784 BRADYCARDIA 220 0.0041
785 EAR INFECTION 110 0.0041
786 TRANSIENT ISCHAEMIC ATTACK 139 0.0041
787 DYSPNOEA 2321 0.0041
788 TOOTH LOSS 85 0.0041
789 BLOOD CREATINE PHOSPHOKINASE INCREASED 118 0.0041
790 SINUS DISORDER 81 0.0041
791 CYTOKINE RELEASE SYNDROME 82 0.0041
792 BALANCE DISORDER 353 0.0041
793 DISCOMFORT 249 0.0041
794 JOINT STIFFNESS 107 0.0041
795 ARRHYTHMIA 193 0.0041
796 BLOOD POTASSIUM INCREASED 66 0.0041
797 DELUSION 63 0.0041
798 GASTRIC ULCER 77 0.0040
799 PERICARDITIS 68 0.0040
800 MULTIPLE FRACTURES 66 0.0040
801 ARTHRITIS 314 0.0040
802 ACTIVITIES OF DAILY LIVING IMPAIRED 79 0.0040
803 EYE PAIN 225 0.0040
804 PLATELET COUNT DECREASED 425 0.0040
805 TYPE 2 DIABETES MELLITUS 134 0.0040
806 DYSSTASIA 116 0.0040
807 VAGINAL HAEMORRHAGE 172 0.0040
808 HEPATIC FUNCTION ABNORMAL 146 0.0039
809 THERAPEUTIC PRODUCT EFFECT DECREASED 174 0.0039
810 DIALYSIS 55 0.0039
811 MUSCLE SPASMS 711 0.0039
812 APHONIA 54 0.0039
813 COLD SWEAT 68 0.0039
814 BLOOD TRIGLYCERIDES INCREASED 68 0.0038
815 PRURITUS GENERALISED 83 0.0038
816 EMOTIONAL DISORDER 118 0.0038
817 NASAL CONGESTION 224 0.0038
818 MIGRAINE 363 0.0038
819 FATIGUE 2959 0.0038
820 INSOMNIA 1012 0.0038
821 HERPES ZOSTER 218 0.0038
822 VISUAL ACUITY REDUCED 126 0.0038
823 PNEUMONITIS 103 0.0038
824 BASAL CELL CARCINOMA 59 0.0038
825 HYPERHIDROSIS 487 0.0038
826 MUSCULOSKELETAL DISCOMFORT 65 0.0038
827 EXTRAPYRAMIDAL DISORDER 93 0.0037
828 PRODUCT USE COMPLAINT 59 0.0037
829 SKIN DISCOLOURATION 172 0.0037
830 IMMUNODEFICIENCY 55 0.0037
831 WEIGHT INCREASED 826 0.0037
832 JOINT SWELLING 444 0.0037
833 SEIZURE 424 0.0037
834 DISTURBANCE IN ATTENTION 197 0.0036
835 OXYGEN SATURATION DECREASED 205 0.0036
836 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 656 0.0036
837 EPISTAXIS 272 0.0036
838 SUICIDAL IDEATION 330 0.0036
839 TREATMENT NONCOMPLIANCE 197 0.0036
840 CARDIAC FAILURE CONGESTIVE 289 0.0036
841 VISION BLURRED 493 0.0036
842 MOVEMENT DISORDER 115 0.0036
843 RHINORRHOEA 231 0.0036
844 APATHY 52 0.0036
845 DISEASE PROGRESSION 420 0.0035
846 LOSS OF CONSCIOUSNESS 454 0.0035
847 POLLAKIURIA 147 0.0035
848 BLOOD PRESSURE ABNORMAL 70 0.0035
849 KIDNEY INFECTION 69 0.0035
850 PERIPHERAL SWELLING 538 0.0035
851 NEUTROPHIL COUNT DECREASED 141 0.0035
852 MEDICATION ERROR 192 0.0035
853 HYPOTHYROIDISM 110 0.0034
854 DISABILITY 68 0.0034
855 POOR QUALITY SLEEP 74 0.0034
856 PSYCHOMOTOR HYPERACTIVITY 57 0.0034
857 MOBILITY DECREASED 244 0.0034
858 MUSCLE TIGHTNESS 55 0.0034
859 COGNITIVE DISORDER 158 0.0034
860 ARTHROPATHY 186 0.0033
861 SNEEZING 75 0.0033
862 COUGH 927 0.0033
863 BONE PAIN 191 0.0033
864 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 76 0.0033
865 RESTLESS LEGS SYNDROME 58 0.0032
866 INTENTIONAL PRODUCT MISUSE 279 0.0032
867 FLUSHING 323 0.0032
868 RENAL DISORDER 147 0.0032
869 RESPIRATORY DISORDER 94 0.0031
870 THIRST 56 0.0031
871 NIGHTMARE 108 0.0031
872 ABASIA 77 0.0031
873 CEREBRAL INFARCTION 76 0.0031
874 SKIN EXFOLIATION 262 0.0031
875 ILLNESS 319 0.0031
876 VISUAL IMPAIRMENT 382 0.0031
877 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 148 0.0031
878 CEREBRAL HAEMORRHAGE 109 0.0030
879 FIBROMYALGIA 74 0.0030
880 ASTHMA 343 0.0030
881 GASTRIC DISORDER 104 0.0030
882 SURGERY 177 0.0030
883 ROAD TRAFFIC ACCIDENT 126 0.0030
884 WHITE BLOOD CELL COUNT DECREASED 325 0.0030
885 FEELING ABNORMAL 711 0.0030
886 THROAT IRRITATION 133 0.0030
887 PRODUCT USE ISSUE 554 0.0029
888 IRRITABILITY 177 0.0029
889 NASOPHARYNGITIS 540 0.0029
890 AGEUSIA 73 0.0029
891 INFLUENZA 325 0.0029
892 LABORATORY TEST ABNORMAL 86 0.0029
893 URINARY RETENTION 97 0.0029
894 RESPIRATORY ARREST 80 0.0029
895 PRODUCT PRESCRIBING ERROR 69 0.0029
896 HERNIA 56 0.0029
897 HYPOACUSIS 123 0.0029
898 ABNORMAL BEHAVIOUR 113 0.0028
899 LIMB INJURY 77 0.0028
900 HIP FRACTURE 91 0.0028
901 BLINDNESS 115 0.0028
902 MENORRHAGIA 54 0.0027
903 AMNESIA 176 0.0027
904 INFLUENZA LIKE ILLNESS 221 0.0027
905 CARDIAC FAILURE 215 0.0027
906 FALL 890 0.0027
907 DEVICE DISLOCATION 116 0.0027
908 COVID-19 467 0.0027
909 INCORRECT PRODUCT ADMINISTRATION DURATION 57 0.0026
910 SEDATION 68 0.0026
911 LACRIMATION INCREASED 78 0.0026
912 MOOD ALTERED 70 0.0026
913 NERVOUSNESS 134 0.0026
914 CONTRAINDICATED PRODUCT ADMINISTERED 77 0.0025
915 HOT FLUSH 191 0.0025
916 HYPERSOMNIA 72 0.0025
917 UNEVALUABLE EVENT 190 0.0025
918 SYSTEMIC LUPUS ERYTHEMATOSUS 88 0.0025
919 FLUID RETENTION 125 0.0025
920 TARDIVE DYSKINESIA 69 0.0024
921 EYE DISORDER 80 0.0024
922 MEMORY IMPAIRMENT 333 0.0024
923 INTENTIONAL DOSE OMISSION 69 0.0024
924 INTERSTITIAL LUNG DISEASE 116 0.0024
925 EYE PRURITUS 80 0.0024
926 OSTEONECROSIS 78 0.0024
927 ABNORMAL DREAMS 65 0.0024
928 DRUG EFFECT INCOMPLETE 85 0.0023
929 HEAD INJURY 74 0.0023
930 DRY EYE 114 0.0023
931 CATARACT 136 0.0023
932 ECZEMA 118 0.0023
933 DIABETIC KETOACIDOSIS 54 0.0022
934 ILL-DEFINED DISORDER 135 0.0022
935 PSORIASIS 284 0.0022
936 SUICIDE ATTEMPT 131 0.0022
937 ALOPECIA 418 0.0021
938 DEMENTIA 59 0.0021
939 RHEUMATOID ARTHRITIS 228 0.0020
940 MYOCARDIAL INFARCTION 346 0.0020
941 ACNE 150 0.0020
942 ACCIDENTAL OVERDOSE 70 0.0019
943 CEREBROVASCULAR ACCIDENT 323 0.0019
944 THERAPEUTIC RESPONSE DECREASED 114 0.0019
945 AGGRESSION 94 0.0019
946 PLASMA CELL MYELOMA 73 0.0019
947 NEOPLASM PROGRESSION 64 0.0018
948 MALIGNANT NEOPLASM PROGRESSION 188 0.0018
949 OVERDOSE 390 0.0018
950 SKIN BURNING SENSATION 129 0.0018
951 MOOD SWINGS 57 0.0018
952 THERAPEUTIC RESPONSE UNEXPECTED 80 0.0018
953 PRODUCT DOSE OMISSION ISSUE 513 0.0017
954 ADVERSE DRUG REACTION 155 0.0017
955 DRY SKIN 227 0.0017
956 OCULAR HYPERAEMIA 80 0.0017
957 DEVICE ISSUE 149 0.0017
958 EYE IRRITATION 94 0.0016
959 INCORRECT DOSE ADMINISTERED 370 0.0016
960 DEVICE BREAKAGE 65 0.0016
961 ANGER 54 0.0016
962 HOSPITALISATION 243 0.0016
963 CARDIAC DISORDER 147 0.0016
964 THERAPY CESSATION 80 0.0016
965 BLOOD GLUCOSE DECREASED 72 0.0015
966 PRODUCT DOSE OMISSION 97 0.0015
967 MULTIPLE SCLEROSIS 70 0.0015
968 NEOPLASM MALIGNANT 97 0.0015
969 INTENTIONAL OVERDOSE 92 0.0014
970 PSORIATIC ARTHROPATHY 57 0.0014
971 BLOOD GLUCOSE INCREASED 262 0.0014
972 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 91 0.0013
973 DEATH 1097 0.0013
974 UNDERDOSE 92 0.0013
975 DERMATITIS ATOPIC 66 0.0013
976 DRUG EFFECT DECREASED 67 0.0012
977 ADVERSE EVENT 110 0.0012
978 INJECTION SITE PAIN 356 0.0012
979 SKIN IRRITATION 52 0.0011
980 INJECTION SITE BRUISING 89 0.0011
981 THERAPY INTERRUPTED 79 0.0011
982 INJECTION SITE ERYTHEMA 135 0.0011
983 INJECTION SITE SWELLING 83 0.0011
984 COMPLETED SUICIDE 85 0.0010
985 INJECTION SITE PRURITUS 68 0.0010
986 INJECTION SITE REACTION 68 0.0010
987 DRUG DOSE OMISSION 157 0.0009
988 INJECTION SITE HAEMORRHAGE 74 0.0009
989 NO ADVERSE EVENT 162 0.0009
990 PRODUCT QUALITY ISSUE 115 0.0008
991 MULTIPLE SCLEROSIS RELAPSE 58 0.0008
992 DEVICE DIFFICULT TO USE 55 0.0008
993 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 163 0.0008
994 DRUG WITHDRAWAL SYNDROME 65 0.0007
995 DRUG DEPENDENCE 95 0.0006
996 BREAST CANCER 54 0.0006